EQT Foundation opens applications for breakthrough research grant in rare diseases
Comunicato Precedente
Comunicato Successivo
The program seeks research at the intersection of deeptech innovation and clinical application, with a focus on:
Cilia Holmes Indahl, CEO, EQT Foundation, comments: "Rare diseases often go unseen and unheard, leaving millions, many of them children, without effective treatments or timely diagnoses. Through this fast-track grant program, we're not just funding research, we're supporting bold scientists to make the leap from lab to clinic. We believe breakthrough technologies can help improve treatments for rare diseases in cost-effective ways, representing an interesting new area for impact investors looking to improve quality-adjusted life years."
In addition to funding, the grantees will benefit from access to EQT's global network, connecting them with advisors, potential industry partners, and commercialization support tailored to the needs of translational science.
Applications open on September 2, 2025, and close on October 1, 2025, at 23:59 CET. Proposals will be reviewed by a panel of scientific and translational experts. Shortlisted applicants will be invited to interview with the EQT Foundation team, with final decisions communicated shortly thereafter.
To apply, visit: https://eqtgroup.com/eqt-foundation/grant-submission
1United Nations General Assembly, Addressing the Challenges of Persons Living with a Rare Disease and Their Families (A/RES/76/132), 2021
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/eqt-foundation-opens-applications-for-breakthrough-research-grant-in-rare-diseases,c4228486
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/eqt-foundation-opens-applications-for-breakthrough-research-grant-in-rare-diseases-302543786.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




